Endogenous metabolite / ergogenic supplement

Plain-language summaryIntrigue 75 / 100

Creatine is a small organic acid your body builds from arginine, glycine, and methionine, and stores almost entirely in skeletal muscle as phosphocreatine. The phosphocreatine pool serves as a rapid phosphate donor that regenerates ATP during high-intensity exercise. Supplementation expands that pool by roughly 20 to 40 percent, which translates to consistent gains of 5 to 10 percent in strength and power output across hundreds of trials. It is the most thoroughly studied ergogenic supplement, with stronger evidence than essentially anything else in the sports nutrition aisle. Newer research has expanded into cognition, neurodegenerative disease, and depression on the theory that creatine kinase activity matters in the brain too. Loading at 20 g per day for five days saturates muscle as fast as 3 to 5 g per day over three to four weeks. Not stocked by Kodiac. This monograph is provided for research and educational reference.

Intrigue 0–100 blends mechanism novelty, evidence strength, and translational potential. Kodiac editorial, not peer-reviewed.

Our opinion on this compoundResearch workhorse

38/100

The gold standard ergogenic reference compound, too settled to be a compelling research target

Cap applied Foundational metabolite (max 38)

Look, creatine monohydrate is genuinely excellent at what it does. The phosphocreatine-to-ATP pathway is one of the cleanest mechanisms in exercise physiology, and the evidence base is staggering: hundreds of replicated trials across decades, consistent 5 to 10 percent improvements in strength and power output, meaningful lean mass effects. If you’re doing sport science or exercise physiology, this is the reference standard. You build your protocols around it.

The problem is that none of that makes it an interesting research target right now. The mechanism was settled in the 1990s. The loading vs maintenance debate (20 g/day for 5 days versus 3-5 g/day sustained, same endpoint, different timeline) was resolved years ago. The sourcing landscape is essentially a commodity market, which is great for reliability and terrible for differentiation. When something this well-understood is this cheap and this consistent, it stops being a research frontier and becomes infrastructure.

The emerging cognitive angle is worth noting, and we dont want to dismiss it entirely. Creatine kinase activity in the CNS is real biology, and there are small trials suggesting some signal in traumatic brain injury populations and mild depression. Watanabe and colleagues published on cognitive effects in vegetarians, where baseline brain creatine is predictably lower, and the effect size there is actually interesting. But honest appraisal puts this at the “plausible mechanism, replication needed” stage. It’s not a reason to score the compound higher when the primary ergogenic story has been exhausted for three decades.

What keeps creatines bench value positive is its role as the canonical ergogenic comparator. If you’re testing anything in the energy substrate or high-intensity power output space, you’re measuring against creatine. It’s the reference standard the field uses to anchor effect sizes. That has real utility, but it’s the utility of a ruler, not a discovery.

The score here is intentional. Creatine monohydrate is one of the most effective and well-documented supplements in existence, and we mean that without irony. It scores 38 precisely because this rubric asks about research frontier value, not product quality. A compound that has been fully characterized, whose mechanism generates no new hypotheses, and whose clinical application is essentially saturated is not where a serious bench scientist should be directing attention in 2026. We’d recommend it without hesitation in a protocol stack. We wouldn’t fund a primary research program around it.

Novelty: 12
Mechanism promise: 18
In-category differentiation: 45
Evidence quality: 80
Translational signal: 72
Research bench value: 40

Rationale Creatine monohydrate scores well on evidence quality and translational signal but near-zero on novelty and mechanism, producing a raw calculated score of 42; the foundational metabolite hard cap brings this to 38. The compound is exhaustively characterized and functions as research infrastructure rather than a research frontier.

Endogenous metabolite / ergogenic supplement

A nitrogenous organic acid; the most thoroughly studied ergogenic supplement; phosphocreatine pool expansion supports rapid ATP regeneration during high-intensity exercise.

Abstract

Creatine monohydrate (N-(aminoiminomethyl)-N-methylglycine; CAS 6020-87-7; molecular formula C4H9N3O2 (anhydrous); molecular weight 131.13) is a nitrogenous organic acid biosynthesized in the liver and kidneys from arginine, glycine, and methionine and stored in skeletal muscle (95 percent of body creatine pool). Mechanism: phosphocreatine, the phosphorylated storage form, donates phosphate to ADP via creatine kinase to rapidly regenerate ATP during high-intensity exercise; supplementation expands the muscle phosphocreatine pool by approximately 20 to 40 percent, supporting longer high-intensity efforts. The most thoroughly studied ergogenic supplement, with hundreds of trials demonstrating consistent ~5 to 10 percent improvement in strength and power output and meaningful effects on lean body mass. Emerging interest in cognitive enhancement, neurodegenerative disease (creatine kinase activity in brain), and depression. The 5-day loading protocol (20 g/day) versus daily maintenance (3 to 5 g/day) produces equivalent muscle saturation with maintenance over 3 to 4 weeks. Plasma half-life is approximately 3 hours; muscle storage is the relevant pharmacokinetic measure. Used as the canonical ergogenic supplement in sport science and exercise physiology research.

Read the full monograph

The full reference document covers compound identification, discovery and developmental history, mechanism of action, pharmacokinetics, sourcing and quality verification, and a curated reference list. Embedded inline below; download for offline reading.

KDC-MN-394Open in new tab →

Download PDF →

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human consumption. All information is provided for research and educational purposes only.

Tag: Endogenous metabolite / ergogenic supplement

Creatine Monohydrate

Abstract

Read the full monograph